BioSymetrics is a leading AI-powered drug discovery and data analytics company, focusing on phenotype-based insights to ...

OncoHost, a technology company transforming the approach to precision medicine for improved patient outcomes, today announced a collaboration with Gustave Roussy, the first European cancer center, to ...

Cancers occurring in the mouth, nose, and throat are on the rise in the U.S., especially in younger people. About 60,000 new cases are diagnosed every ...

"Integrating prognostic and predictive biomarkers into clinical care could help to provide more targeted therapies, leading ...

A new assay rapidly detected pancreatic ductal adenocarcinoma and differentiated it from noncancer pancreatic diseases by ...

Strategic Combination Aims to Accelerate Biomarker Identification, Enhance Drug Discovery, and Expand Precision Medicine Applications in Cancer and Beyond LOS ANGELES, Feb. 26, 2025 (GLOBE NEWSWIRE) ...

Improving early detection is one of several holy grails in pancreatic cancer research. Many believe biomarkers — biological ...

SNS Insider Report Highlights 10.04% CAGR Growth Fueled by Technological Breakthroughs and Rising Global Cancer Burden.Pune, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Tumor Profiling Market Size & Growth ...

The Providence Cancer Center at Alaska Medical Center in Anchorage, part of Renton, Wash.-based Providence, will become the first hospital in Alaska to offer the targeted prostate cancer therapy, ...

AI holds immense promise but also demands a careful, measured approach to yield the greatest benefit—especially for cancer ...

Colorectal cancer (CRC) is the second most commonly diagnosed cancer in China and a leading cause of cancer-related mortality ...

Keytruda has been approved since 2016 as a second-line option after chemotherapy for patients with more advanced HNSCC that ...